Orthocell Ltd's (ASX:OCC) Paul Anderson talks Proactive's Andrew Scott through a new US divisional patent they've secured for CelGro® that covers the method of manufacture of collagen medical devices and as an aid in the surgical repair of soft tissue injuries. Orthocell has already been granted patents for CelGro® in the US, Canada, Europe, China, Japan, Singapore, Australia and New Zealand with CelGro® dental (recently renamed Striate+) approved for use in the US, Europe and Australia.
Orthocell Ltd secures new US divisional patent for CelGro®
